.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,071,879

« Back to Dashboard

Details for Patent: 5,071,879

Title: Systemic antiviral treatment
Abstract:Systemic antiviral treatment using a narrow class of aliphatic straight-chain saturated monohydric alcohols which have from 20 to 26, preferably 22 to 26, carbons in the chain in physiologically compatible compositions for injection or trans-mucus membrane introduction into humans and other animals is disclosed.
Inventor(s): Katz; David H. (La Jolla, CA)
Assignee: Lidak Pharmaceuticals (La Jolla, CA)
Filing Date:Nov 02, 1989
Application Number:07/431,304
Claims:1. A method of treating or preventing disease in humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

2. A method of treating or preventing disease in humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated by intramuscular injection a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

3. A method of treating or preventing disease in humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated by transmucus membranal penetration a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

4. A method of treating or preventing disease in humans or other animals, comprising introducing into the human or other animal to be treated by transdermal penetration of a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

5. A method of preventing or inhibiting virus infection of humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

6. A method of preventing or inhibiting virus infection of humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated by intramuscular injection a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

7. A method of preventing or inhibiting virus infection of humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated by transmucus membrane penetration a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

8. A method of preventing or inhibiting virus infection of humans or other animals, comprising introducing into the circulatory system of the human or other animal to be treated by transdermal penetration a composition consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible carrier.

9. A physiologically compatible solution suitable for injection into humans or other animals to prevent or treat disease in such humans or other animals consisting essentially of at least one C-20 to C-26 aliphatic alcohol in a physiologically compatible injectable carrier.

10. A physiologically compatible transdermal medication for introduction through the mucous membranes into humans or other animals consisting essentially of at least one C-20 to C-26 aliphatic alcohol and a penetration enhancer.

11. The method of claim 1 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

12. The method of claim 2 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

13. The method of claim 3 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

14. The method of claim 4 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

15. The method of claim 5 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

16. The method of claim 6 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

17. The method of claim 7 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.

18. The method of claim 8 wherein composition consists essentially of C-22 aliphatic alcohol in a physiologically compatible carrier.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc